More than 100 people, most of whom did not have a gallbladder, who were treated with Viberzi, the new drug to treat irritable bowel syndrome with diarrhea (IBS-D), developed serious pancreatitis, 76 of whom were hospitalized and two of whom died, according to the Food and Drug Administration (FDA). As a result, the agency is advising doctors not to prescribe Viberzi to patients who do not have a gallbladder. Pancreatitis is a painful inflammation of the pancreas. People who suffer from this condition may be at increased risk of developing pancreatic cancer. “Pancreatitis may be caused by spasm of a ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.